Reply to Gorrepati Rohith and Prasant Nayak's Letter to the Editor re: Ranan Dasgupta, Sarah Cameron, Lorna Aucott, et al. Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial. Eur Urol 2021;80:46-54

被引：2

作者：

Dasgupta, Ranan ^{[1
]}

McClinton, Sam ^{[2
]}

机构：

[1] Imperial Coll Hlthcare NHS Trust, St Marys Hosp, Dept Urol, Praed St, London, England

[2] NHS Grampian, Aberdeen Royal Infirm, Dept Urol, Aberdeen, Scotland

来源：

EUROPEAN UROLOGY | 2021年 / 80卷 / 05期

关键词：

D O I：

10.1016/j.eururo.2021.08.016

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E124 / E125

页数：2

共 5 条

[1] Re: Ranan Dasgupta, Sarah Cameron, Lorna Aucott, et al. Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial. Eur Urol 2021;80:46-54
不详
EUROPEAN UROLOGY, 2021, 80 (05) : E119 - E119
[2] Re: Shockwave Lithotripsy versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-Inferiority Trial
Alken, P.
JOURNAL OF UROLOGY, 2022, 207 (04): : 923 - 923
[3] Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial
Dasgupta, Ranan
Cameron, Sarah
Aucott, Lorna
MacLennan, Graeme
Thomas, Ruth E.
Kilonzo, Mary M.
Lam, Thomas B. L.
N'Dow, James
Norrie, John
Anson, Ken
Burgess, Neil
Clark, Charles T.
Keeley, Francis X., Jr.
MacLennan, Sara J.
Starr, Kath
McClinton, Sam
EUROPEAN UROLOGY, 2021, 80 (01) : 46 - 54
[4] Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2022.08.003
Tan, Wei Shen
Mustard, Connor
Kelly, John D.
EUROPEAN UROLOGY, 2023, 83 (02) : E48 - E49
[5] Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Arends, Tom J. H.
Witjes, J. Alfred
EUROPEAN UROLOGY, 2019, 75 (02) : E26 - E26

← 1 →